Capital Growth Management LP Abb Vie Inc. Transaction History

Capital Growth Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $13.3 Million - $15.6 Million	-155,000 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $17.8 Million - $23.9 Million	-243,000 Reduced 61.06%	155,000 $15.2 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $21.5 Million - $32.6 Million	333,000 Added 512.31%	398,000 $30.3 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $4.69 Million - $5.87 Million	65,000 New	65,000 $5.76 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Capital Growth Management LP, based on Form 13F filings with the SEC.

Stay updated on Capital Growth Management LP with notifications on news.